Hyperzincemia and hypercalprotectinemia: unsuccessful treatment with tacrolimus

Acta Paediatr. 2009 Feb;98(2):410-2. doi: 10.1111/j.1651-2227.2008.01092.x. Epub 2008 Nov 4.

Abstract

We report on a 5-year-old boy with hyperzincemia and hypercalprotectinemia. Treatment began with Tacrolimus at the age of 4 years and 6 months. Despite an initial correction of clinical and biological symptoms, zincemia and calprotectinemia progressively worsened with secondary reappearance of symptoms.

Conclusion: Tacrolimus seems to have a transient effect in the treatment of Hyperzincemia and hyperprolactinemia.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Humans
  • Leukocyte L1 Antigen Complex / blood*
  • Male
  • Metabolic Diseases / blood*
  • Metabolic Diseases / drug therapy*
  • Tacrolimus / therapeutic use*
  • Treatment Failure
  • Zinc / blood*

Substances

  • Leukocyte L1 Antigen Complex
  • Zinc
  • Tacrolimus